Follow-The-Filings

RNA Atrium Therapeutics

Atrium Therapeutics earnings company data as of 7:30 PM ET 8/20

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 13 Aug EPS -1.18
Rev $3.0M

SEC filings

Recent issuer filings from EDGAR · 7 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01
10-Q
8-K 8.01,9.01
8-K 2.02,9.01
10-Q
8-K 1.01,5.01,5.02,9.01
8-K 7.01,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 1 row shown

Filed Form Detail Links
4 Period Apr 20, 2026 · 5 forms

17 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice